Files
Download Full Text (433 KB)
Description
Homelessness and opioid use disorder are at the forefront of public health issues in Maine. Substance use accounts for a higher proportion of deaths among those experiencing homelessness than it does in the overall population. In 2022, Maine ranked third in the U.S. for fatal overdoses involving opioids. The clinic at the center of this evaluation is a low-barrier buprenorphine bridge program serving people experiencing homelessness that provides same-day prescriptions and other supports, while connecting patients to ongoing care for substance use disorder.
This was a qualitative program evaluation that used semi-structured key informant interviews. The evaluation focused on assessing internal processes, attitudes and beliefs of employees, and relationships with partner organizations. Participants were included if they are current employees at the clinic or a partner organization. Interviews were conducted via Zoom and recorded. Interviews were coded in Excel using in-vivo coding. Codes were categorized using a color-coding system. Themes were assessed based on codes and categories.
Faculty Advisor(s)
Courtni Jeffers, MS, MPH, EdD
Publication Date
Fall 9-20-2024